The biotech cluster based in Cambridge and Boston, the nation’s largest, grapples with a record 16.1 million square feet of unleased lab space. And hiring remains soft, ...

Flagging stock prices: Massachusetts biotech stocks ended the year down about 1 percent, compared with a 23 percent jump by the Standard & Poor’s 500 index.